Can. 1, 210–221 . 15.Hogan, S.A., Levesque, M.P., and Cheng, P.F. (2018). Melanoma Immuno- therapy: Next-Generation Biomarkers. Front. Oncol. 8,1 7 8 . 16.Nixon, A.B., Schalper, K.A., Jacobs, I., Potluri, S., Wang, I.-M., and Fleener, C. (2019). Peripheral immune-based biomarkers in cancer immu-notherapy: can we realize their predictive potential? J. Immunother. Can-cer7, 325 . 17.Krieg, C., Nowicka, M., Guglietta, S., Schindler, S., Hartmann, F.J., Weber, L.M., Dummer, R., Robinson, M.D., Levesque, M.P., and Becher, B.(2018). High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy. Nat.